•COGNIBET Injection (Cerebroprotein Hydrolysate 60mg): A Neuroprotective and Neurotrophic Peptide Therapy
COGNIBET Injection contains Cerebroprotein Hydrolysate 60mg, a preparation of biologically active neuropeptides and amino acids used as a neuroprotective and neurotrophic therapy. It is prescribed as an adjunctive treatment in selected neurological conditions, including ischemic stroke recovery, traumatic brain injury, and certain forms of cognitive impairment, depending on local regulatory approvals and clinical judgment. (1mg)
Cerebroprotein Hydrolysate is believed to support neuronal survival, enhance neuroplasticity, and promote recovery of damaged nerve tissue. It is administered only by qualified healthcare professionals. COGNIBET Injection is generally a prescription-only medicine and should be used under the supervision of a neurologist or other qualified physician. (1mg)
•Key Benefits of COGNIBET Injection (Cerebroprotein Hydrolysate 60mg)
1. Supports neurological recovery following ischemic stroke as part of comprehensive treatment.
2. May aid recovery after traumatic brain injury when used alongside standard medical care.
3. Promotes neuronal repair and neuroplasticity.
4. May help improve cognitive function in selected patients with neurodegenerative disorders when clinically indicated.
5. Injectable formulation provides direct administration under professional supervision.
•How COGNIBET Injection (Cerebroprotein Hydrolysate 60mg) Works
Cerebroprotein Hydrolysate consists of low-molecular-weight neuropeptides and amino acids that can cross the blood-brain barrier and exert neurotrophic effects. It is thought to promote neuronal survival, enhance synaptic plasticity, reduce excitotoxic neuronal injury, improve cerebral metabolism, and stimulate neuroregenerative processes. These multimodal actions may contribute to improved functional recovery following acute neurological injury and support cognitive function in selected patients when used as adjunctive therapy. (Trumac Healthcare)
•Usage Instructions for COGNIBET Injection (Cerebroprotein Hydrolysate 60mg)
1. The injection should be administered intravenously or intramuscularly by trained medical personnel according to approved prescribing guidance.
2. Follow the prescribed treatment schedule without missing doses.
3. Clinical response and neurological status should be monitored throughout therapy.
•Medicinal Advantages of COGNIBET Injection (Cerebroprotein Hydrolysate 60mg)
1. Provides neurotrophic peptide support for neurological recovery.
2. May enhance neuronal repair and functional rehabilitation following brain injury.
3. Supports neuronal metabolism and synaptic function.
4. Can be incorporated into multidisciplinary neurological rehabilitation programs.
5. Administered under medical supervision for individualized treatment planning.
•Off-Label Uses of COGNIBET Injection (Cerebroprotein Hydrolysate 60mg)
1. Adjunctive management of vascular dementia.
2. Supportive treatment for selected cognitive impairment syndromes.
3. Adjunctive therapy in other neurological rehabilitation programs based on specialist assessment.
•Expert Advice for Optimal Use
1. Receive each injection only from qualified healthcare professionals.
2. Participate in prescribed physical, occupational, or cognitive rehabilitation programs.
•Precautions
1. Cardiovascular Health
Patients recovering from stroke or other cardiovascular conditions should receive COGNIBET Injection only as part of an individualized treatment plan with appropriate monitoring.
2. Liver & Kidney Function
Patients with severe kidney impairment require careful evaluation before treatment. Clinical monitoring is recommended in patients with significant renal or hepatic disease. (1mg)
3. Pregnancy & Breastfeeding
The safety of Cerebroprotein Hydrolysate during pregnancy and breastfeeding has not been well established. It should be used only if the expected benefit justifies the potential risk, following medical assessment.
•Storage Instructions
1. Protect from direct sunlight and excessive moisture.
2. Do not freeze the injection unless specifically stated by the manufacturer.
3. Keep the vial or ampoule in its original packaging until use.
4. Keep out of the reach of children.
•Frequently Asked Questions (FAQs)
Q: What is COGNIBET Injection used for?
A: It is prescribed as an adjunctive treatment for selected neurological conditions such as ischemic stroke recovery, traumatic brain injury, and certain cognitive disorders, depending on local approvals and physician assessment.
Q: Is COGNIBET Injection a prescription medicine?
A: Yes. It is generally available only with a valid prescription and should be administered by qualified healthcare professionals.
Q: How is COGNIBET Injection administered?
A: It is administered by intravenous or intramuscular injection under medical supervision according to the prescribed treatment regimen.
